Results 341 to 349 of about 123,443 (349)

Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

Nature Neuroscience, 2007
Pal Pacher, Irmgard Tegeder, Fumimasa Amaya   +2 more
exaly  

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

Drug and Alcohol Dependence, 2014
Marisol S Castaneto, Rebecca L Hartman, Marilyn A Huestis   +2 more
exaly  

An update on PPAR activation by cannabinoids

British Journal of Pharmacology, 2016
Saoirse E O'sullivan
exaly  

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

Lancet, The, 2003
Andrew Nunn, Alan J Thompson
exaly  

Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review

Biological Psychiatry, 2016
Murat Yücel, Nadia Solowij
exaly  

Cannabinoids reveal importance of spike timing coordination in hippocampal function

Nature Neuroscience, 2006
David Robbe, Pavel E Rueda-Orozco, Gyorgy Buzsaki   +2 more
exaly  

Pharmacokinetics and Pharmacodynamics of Cannabinoids

Clinical Pharmacokinetics, 2003
F. Grotenhermen
semanticscholar   +1 more source

Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis

World Psychiatry, 2016
Robin M Murray, Harriet Quigley, Diego Quattrone   +2 more
exaly  

Pharmacokinetics and Pharmacodynamics of Cannabinoids

Clinical Pharmacokinetics, 2012
exaly